Le Lézard
Classified in: Health
Subjects: TDS, MAT

Neptune CEO, Michael Cammarata to Participate in Exclusive 'Transforming Brands for the Next Generation of Consumers' Interview at the Benzinga Cannabis Capital Conference on April 21, 2022


LAVAL, QUÉBEC, April 13, 2022 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced that Michael Cammarata, Chief Executive Officer, will participate in an exclusive interview at the Benzinga Cannabis Capital Conference on April 21, 2022.


Topic:               

Transforming Brands for the Next Generation of Consumers


Moderator:       

Jeremy Berke, Senior Reporter at Business Insider 


Date:                 

April 21, 2022


Time:                 

11:45 a.m. ET


Registration:     

https://www.benzinga.com/events/cannabis-conference/

"I'm looking forward to participating in a fireside chat at the Benzinga Cannabis Capital Conference and sharing insights into Neptune and the exciting opportunities ahead, especially within the consumer packaged goods industry," said Michael Cammarata, Chief Executive Officer and President of Neptune Wellness. "Benzinga offers the invaluable opportunity to learn from and network with leaders across our industry, and we're proud to be a part of it."

"It's an honor to count on the presence of a speaker of the level of Michael Cammarata at our Miami event," said Chief Zinger Jason Raznick. "The Benzinga Cannabis Capital Conference in Miami will bring more than 1,000 of the top movers and shakers in the cannabis industry to our back yard. This conference will be the best place to raise money, create partnerships, and expand media visibility for all involved."

To schedule a one-on-one investor meeting with Neptune's management team, please contact a conference representative or KCSA Strategic Communications by emailing [email protected].

About Neptune Wellness Solutions Inc.

Headquartered in Laval, Quebec, Neptune is a diversified health and wellness company with a mission to redefine health and wellness. Neptune is focused on building a portfolio of high quality, affordable consumer products in response to long-term secular trends and market demand for natural, plant-based, sustainable and purpose-driven lifestyle brands. The Company utilizes a highly flexible, cost-efficient manufacturing and supply chain infrastructure that can be scaled to quickly adapt to consumer demand and bring new products to market through its mass retail partners and e-commerce channels. For additional information, please visit: https://neptunewellness.com/.

About The Benzinga Cannabis Capital Conference

The Benzinga Cannabis Capital Conference, renowned for being the premier gathering of cannabis entrepreneurs and investors in North America, returns for another edition, recharged with an impressive list of speakers. Check out the full lineup here.

Disclaimer ? Safe Harbor Forward?Looking Statements

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Neptune Wellness Solutions to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

SOURCE Neptune Wellness Solutions Inc.


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: